share price recovery, page-3

Look, I'm shattered, but I wish people would stop talking like we're dead.
It's nothing like PXS, the efficacy of Bronchitol was questioned. Despite posts from classless non-holders today, the safety nor efficacy of Moxduo is NOT in question. It is about the combination rule, and the requirement to prove to be as good as either morpheine or oxycodone individually. This has been done supposedly.

The article in the Australian is out of line imo.

I honestly believe everyone was blindsided by this, including the company. I have faith that they are doing their best. In none of the many meetings with the FDA have they brought this up as being an issue.

I do not believe we will need further trials, and we now need to wait until the meeting in August to establish the problem.

A good post on a bad day Emark. I hope it can come back a little from here at least.